VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 65 filers reported holding VERSARTIS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $2,042,000 | -74.3% | 117,043 | -68.5% | 0.14% | -67.9% |
| Q1 2017 | $7,944,000 | +4.2% | 372,069 | -27.3% | 0.44% | +18.2% |
| Q4 2016 | $7,623,000 | +29.4% | 511,610 | +6.4% | 0.37% | +36.7% |
| Q3 2016 | $5,893,000 | +68.5% | 481,056 | +52.1% | 0.27% | +40.6% |
| Q2 2016 | $3,498,000 | +97.2% | 316,244 | +42.9% | 0.19% | +95.9% |
| Q1 2016 | $1,774,000 | -72.5% | 221,244 | -57.6% | 0.10% | -68.8% |
| Q4 2015 | $6,458,000 | -18.5% | 521,244 | -24.2% | 0.31% | -17.8% |
| Q3 2015 | $7,927,000 | -41.8% | 687,484 | -23.2% | 0.38% | -28.3% |
| Q2 2015 | $13,630,000 | +4.0% | 895,531 | +25.5% | 0.53% | -4.1% |
| Q1 2015 | $13,106,000 | -9.4% | 713,443 | +10.8% | 0.56% | -11.6% |
| Q4 2014 | $14,461,000 | +37.5% | 644,150 | +16.3% | 0.63% | +33.3% |
| Q3 2014 | $10,516,000 | -1.1% | 553,769 | +46.0% | 0.47% | +15.7% |
| Q2 2014 | $10,629,000 | – | 379,200 | – | 0.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
| Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
| Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
| Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
| HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
| Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
| RA Capital Management | 231,267 | $5,192,000 | 0.56% |
| Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
| PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |